For the Inventor, By the Inventor

Enter assignee name

Philadelphia, PA, United States of America

Oncoceutics, Inc.

USPTO Granted Patents = 14

EPO Patents = 7

Forward Citations = 31

Loading Chart...

Loading Chart...

8 inventors (with patents filed for the assignee):

Joshua E Allen (14 out of 24 patents)

Martin Stogniew (14 out of 49 patents)

Varun Vijay Prabhu (5 out of 5 patents)

4. Richard S Pottorf (5 out of 6 patents)

5. Bhaskara Rao Nallaganchu (5 out of 10 patents)

6. Gary Olson (5 out of 31 patents)

7. Yanjun Sun (3 out of 6 patents)

8. Gary L Olson (0 patent)

9. Gary L Olson (0 patent)

14 patents: Sort by Forward Citations

1. 12102639 - Imipridones for gliomas (2024-10-01),

2. 11976068 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2024-05-07),

3. 11116771 - G protein-coupled receptor (GPCR) modulation by imipridones (2021-09-14),

4. 10953014 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2021-03-23),

5. 10946022 - Imipridones for gliomas (2021-03-16),

6. 10456402 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2019-10-29),

7. 10369154 - Imipridones for gliomas (2019-08-06),

8. 10266533 - 7-Benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2019-04-23),

9. 10172862 - Imipridones for gliomas (2019-01-08),

10. 10045992 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5 (1h)-one, salts thereof and methods of using the same in combination therapy (2018-08-14),

11. 9845324 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo [1,2-A]pyrido[3,4-E]pyrimidin-5(1H)-one, analogs thereof, and salts thereof and methods for their use in therapy (2017-12-19),

12. 9688679 - 7-benzyl-4-(methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-A]pyrido[3,4-E]pyrimidin-5 (1H)-one, salts thereof and methods of using the same in combination therapy (2017-06-27),

13. 9376437 - 7-benzyl-4-(2-methylbenzyl)-2,4,6,7,8,9-hexahydroimidazo[1,2-a]pyrido[3,4-e]pyrimidin-5(1H)-one, salts thereof and methods of using the same in combination therapy (2016-06-28),

14. 9265765 - 7-benzyl-10-(2-methylbenzyl)-2,6,7,8,9,10-hexahydroimidazo[1,2-A]pyrido[4,3-D]pyrimidin-5(3H)-one, salts thereof and methods of using the same in combination therapy (2016-02-23),

Oncoceutics, Inc. is a biopharmaceutical company based in Philadelphia, PA, focused on developing innovative therapies for cancer treatment. The organization specializes in the research and development of novel compounds aimed at targeting specific cancer pathways, with an emphasis on improving patient outcomes. By leveraging advanced scientific insights and technologies, Oncoceutics seeks to address unmet medical needs in oncology, contributing to the evolving landscape of cancer care.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

14 Patents

#72 in Philadelphia, PA

#803 in Pennsylvania

#22,302 in US

#42,199 in the World

Philadelphia, PA, United States of America

Oncoceutics, Inc.

Forward Citations = 31

8 inventors:

Joshua E Allen (14 out of 24 patents)

Martin Stogniew (14 out of 49 patents)

Varun Vijay Prabhu (5 out of 5 patents)

4. Richard S Pottorf (5 out of 6 patents)

5. Bhaskara Rao Nallaganchu (5 out of 10 patents)

Please report any incorrect information to [email protected]

Loading…